Back
Akebia Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
AKBA
Akebia Therapeutics, Inc.
Last Price:
$1.67
Seasonality Move:
43.42%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and AKBA is experiencing selling pressure, which indicates risk of future bearish movement.
Akebia Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.64 | Buy |
| 20-day SMA: | 1.59 | Buy |
| 50-day SMA: | 2.05 | Sell |
| 200-day SMA: | 2.71 | Sell |
| 8-day EMA: | 1.63 | Buy |
| 20-day EMA: | 1.67 | Sell |
| 50-day EMA: | 1.98 | Sell |
| 200-day EMA: | 2.44 | Sell |
Akebia Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 44.71 | Sell |
| Chaikin Money Flow: | -4378916 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.54 - 1.66) | Buy |
| Bollinger Bands (100): | (1.88 - 3.24) | Sell |
Akebia Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akebia Therapeutics, Inc. Stock
Is Akebia Therapeutics, Inc. Stock a Buy?
-
Akebia Therapeutics, Inc. share price is 1.66 while AKBA 8-day simple moving average is 1.64, which is a Buy signal.
-
The stock price of AKBA is 1.66 while Akebia Therapeutics, Inc. 20-day SMA is 1.59, which makes it a Buy.
-
Akebia Therapeutics, Inc. 50-day simple moving average is 2.05 while AKBA share price is 1.66, making it a Sell technically.
-
AKBA stock price is 1.66 and Akebia Therapeutics, Inc. 200-day simple moving average is 2.71, creating a Sell signal.
AKBA Technical Analysis vs Fundamental Analysis
Sell
41
Akebia Therapeutics, Inc. (AKBA)
is a Sell
Is Akebia Therapeutics, Inc. a Buy or a Sell?
-
Akebia Therapeutics, Inc. stock is rated a SellThe current Akebia Therapeutics, Inc. [AKBA] share price is $1.66. The Score for AKBA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Akebia Therapeutics, Inc. Stock Info
Market Cap:
440.5M
Price in USD:
1.66
Share Volume:
5.4M
Akebia Therapeutics, Inc. 52-Week Range
52-Week High:
4.08
52-Week Low:
1.45
Sell
41
Akebia Therapeutics, Inc. (AKBA)
is a Sell
Akebia Therapeutics, Inc. Share Price Forecast
-
What is the Akebia Therapeutics, Inc. stock price today?The Akebia Therapeutics, Inc. stock price is 1.66 USD today.
-
Will AKBA stock go up or go down?Akebia Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Akebia Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akebia Therapeutics, Inc. is overvalued.
Is Akebia Therapeutics, Inc. Stock a Buy?
-
Akebia Therapeutics, Inc. share price is 1.66 while AKBA 8-day exponential moving average is 1.63, which is a Buy signal.
-
The stock price of AKBA is 1.66 while Akebia Therapeutics, Inc. 20-day EMA is 1.67, which makes it a Sell.
-
Akebia Therapeutics, Inc. 50-day exponential moving average is 1.98 while AKBA share price is 1.66, making it a Sell technically.
-
AKBA stock price is 1.66 and Akebia Therapeutics, Inc. 200-day simple moving average is 2.44, creating a Sell signal.
Fundamental Analysis of Akebia Therapeutics, Inc.
Is Akebia Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.13 per share.
Technical Analysis of Akebia Therapeutics, Inc.
Should I short Akebia Therapeutics, Inc. stock?
-
AKBA Moving Average Covergence Divergence (MACD) indicator is -0.09, suggesting Akebia Therapeutics, Inc. is a Sell
-
Akebia Therapeutics, Inc. Relative Strength Index (RSI) is 44.71, which suggest Akebia Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Akebia Therapeutics, Inc. is (1.54 - 1.66), which suggest Akebia Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Akebia Therapeutics, Inc. is (1.88 - 3.24), which suggest Akebia Therapeutics, Inc. is a Sell
* Akebia Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.